These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 38128649)

  • 1. Mobile treatment for opioid use disorder: Implementation of community-based, same-day medication access interventions.
    Chatterjee A; Baker T; Rudorf M; Walt G; Stotz C; Martin A; Kinnard EN; McAlearney AS; Bosak J; Medley B; Pinkhover A; Taylor JL; Samet JH; Lunze K
    J Subst Use Addict Treat; 2024 Apr; 159():209272. PubMed ID: 38128649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mobile addiction treatment and harm reduction services as tools to address health inequities: a community case study of the Brockton Neighborhood Health Center mobile unit.
    Pinkhover A; Celata K; Baker T; Chatterjee A; Lunze K
    Front Public Health; 2024; 12():1407522. PubMed ID: 38957203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medication for opioid use disorder treatment continuity post-release from jail: A qualitative study with community-based treatment providers.
    Stopka TJ; Rottapel RE; Ferguson WJ; Pivovarova E; Toro-Mejias LD; Friedmann PD; Evans EA
    Int J Drug Policy; 2022 Dec; 110():103803. PubMed ID: 35965159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Referral to and engagement in substance use disorder treatment within opioid intervention courts in New York: a qualitative study of implementation barriers and facilitators.
    O'Grady MA; Elkington KS; Robson G; Achebe IY; Williams AR; Cohall AT; Cohall R; Christofferson M; Garcia A; Ramsey KS; Lincourt P; Tross S
    Subst Abuse Treat Prev Policy; 2024 Jan; 19(1):12. PubMed ID: 38287329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stakeholder perspectives on a telemedicine referral and coordination model to expand medication treatment for opioid use disorder in rural primary care clinics.
    Ober AJ; Dopp AR; Clingan SE; Curtis ME; Lin C; Calhoun S; Larkins S; Black M; Hanano M; Osterhage KP; Baldwin LM; Saxon AJ; Hichborn EG; Marsch LA; Mooney LJ; Hser YI
    J Subst Use Addict Treat; 2024 Jan; 156():209194. PubMed ID: 37863356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implementation of medication for opioid use disorder treatment in Indian health clinics in California: A qualitative evaluation.
    Soto C; Miller K; Moerner L; Nguyen V; Ramos GG
    J Subst Use Addict Treat; 2023 Dec; 155():209115. PubMed ID: 37399928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical stakeholders' perceptions of patient engagement in outpatient medication treatment for opioid use disorder: A qualitative study.
    Poulsen MN; Roe SA; Asdell PB; Rahm AK; Berrettini W
    J Subst Use Addict Treat; 2024 Mar; 158():209250. PubMed ID: 38072381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "Sick and tired of being sick and tired": Exploring initiation of medications for opioid use disorder among people experiencing homelessness.
    Swartz N; Adnan T; Peréa F; Baggett TP; Chatterjee A
    J Subst Abuse Treat; 2022 Jul; 138():108752. PubMed ID: 35277306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An economic analysis of the cost of mobile units for harm reduction, naloxone distribution, and medications for opioid use disorder.
    Castry M; Tin Y; Feder NM; Lewis N; Chatterjee A; Rudorf M; Samet JH; Beers D; Medley B; Gilbert L; Linas BP; Barocas JA
    J Subst Use Addict Treat; 2024 Dec; 167():209517. PubMed ID: 39299504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lessons Learned from Implementation of a Post-opioid Overdose Outreach Program in a Rural Massachusetts Community.
    Senthilkumar R; Bailey A; Moner E; Parduhn T; Evans EA
    Community Ment Health J; 2024 Apr; 60(3):482-493. PubMed ID: 37902945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protocol for community-driven selection of strategies to implement evidence-based practices to reduce opioid overdoses in the HEALing Communities Study: a trial to evaluate a community-engaged intervention in Kentucky, Massachusetts, New York and Ohio.
    Young AM; Brown JL; Hunt T; Sprague Martinez LS; Chandler R; Oga E; Winhusen TJ; Baker T; Battaglia T; Bowers-Sword R; Button A; Fallin-Bennett A; Fanucchi L; Freeman P; Glasgow LM; Gulley J; Kendell C; Lofwall M; Lyons MS; Quinn M; Rapkin BD; Surratt HL; Walsh SL
    BMJ Open; 2022 Sep; 12(9):e059328. PubMed ID: 36123106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Scoping Review of Barriers and Facilitators to Implementation of Medications for Treatment of Opioid Use Disorder within the Criminal Justice System.
    Grella CE; Ostile E; Scott CK; Dennis M; Carnavale J
    Int J Drug Policy; 2020 Jul; 81():102768. PubMed ID: 32446130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "And Then COVID Hits": A Qualitative Study of How Jails Adapted Services to Treat Opioid Use Disorder During COVID-19.
    Harrington C; Bailey A; Delorme E; Hano S; Evans EA
    Subst Use Misuse; 2023; 58(2):266-274. PubMed ID: 36510800
    [No Abstract]   [Full Text] [Related]  

  • 14. Provider perceptions of medication for opioid used disorder (MOUD): A qualitative study in communities with high opioid overdose death rates.
    Paul N; Kennedy AJ; Taubenberger S; Chang JC; Hacker K
    Subst Abus; 2022; 43(1):742-748. PubMed ID: 35100094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The development of a recovery coaching training curriculum to facilitate linkage to and increase retention on medications for opioid use disorder.
    Moffitt T; Fallin-Bennett A; Fanucchi L; Walsh SL; Cook C; Oller D; Ross A; Gallivan M; Lauckner J; Byard J; Wheeler-Crum P; Lofwall MR
    Front Public Health; 2024; 12():1334850. PubMed ID: 38425462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Jail-based reentry programming to support continued treatment with medications for opioid use disorder: Qualitative perspectives and experiences among jail staff in Massachusetts.
    Matsumoto A; Santelices C; Evans EA; Pivovarova E; Stopka TJ; Ferguson WJ; Friedmann PD
    Int J Drug Policy; 2022 Nov; 109():103823. PubMed ID: 35994938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Provision of medications to treat opioid use disorder via a mobile health unit: A scoping review.
    Bailey A; DaCunha A; Napoleon SC; Kang AW; Kemo M; Martin RA
    J Subst Use Addict Treat; 2024 Sep; 164():209431. PubMed ID: 38852822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The HEALing (Helping to End Addiction Long-term
    HEALing Communities Study Consortium
    Drug Alcohol Depend; 2020 Dec; 217():108335. PubMed ID: 33248391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Facilitators and barriers to collaboration between drug courts and community-based medication for opioid use disorder providers.
    Pivovarova E; Taxman FS; Boland AK; Smelson DA; Lemon SC; Friedmann PD
    J Subst Use Addict Treat; 2023 Apr; 147():208950. PubMed ID: 36804347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expert providers implement integrated and coordinated care in opioid use disorder treatment.
    Harris LM; Guerrero EG; Khachikian T; Serrett V; Marsh JC
    Int J Drug Policy; 2024 Oct; 132():104567. PubMed ID: 39241532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.